Skip to main content

Subacute Cutaneous and Systemic Lupus Erythematosus

  • Chapter
Autoimmune Diseases of the Skin

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

eBook
USD 13.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ahearn JM, Provost TT, Dorsch CA, Stevens MB, Bias WB, Arnett FC (1982) Interrelationships of HLA-DR, MB and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum 25: 1031–1040

    PubMed  Google Scholar 

  • Amato L, Coronella G, Berti S, Moretti S, Fabbri P (2003) Subacute cutaneous lupus erythematosus in childhood. Pediatric Dermatol 20(1):31–4

    Google Scholar 

  • Ashworth J (1992) Subacute cutaneous lupus erythematosus in a patient with Crohn’s disease. Clin Exp Dermatol 17: 135–136

    PubMed  Google Scholar 

  • Azurdia RM, Pagliaro JA, Diffey BL, Rhodes LE (1999) Sunscreen application by photosensitive patients is inadequate for protection. Br J Dermatol 140: 255–258

    PubMed  Google Scholar 

  • Balbanova MB, Botev IN, Michailoba JI (1997) Subacute cutaneous lupus erthematosus induced by radiation therapy. Br J Dermatol 137: 648–649

    PubMed  Google Scholar 

  • Bangert JL, Freeman RG, Sontheimer RD, Gilliam JN (1984) Comparative histopathology of subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Arch Dermatol 120: 332

    Article  PubMed  Google Scholar 

  • Barilla-LaBarca ML, Atkinson JP (2000) Rheumatic syndromes associated with complement deficiency. Current Opinion in Rheumatol 15: 55–60

    Article  Google Scholar 

  • Bell DA, Maddison PJ (1980) Serologic subsets in systemic lupus erythematosus. Arthritis Rheum 23: 1268–1273

    PubMed  Google Scholar 

  • Bielsa I, Herrero C, Font J, Mascaro JM (1987) Lupus erythematosus and toxic epidermal necrolysis. J Am Acad Dermatol 16: 1265–1267

    PubMed  Google Scholar 

  • Black DR, Hornung CA, Schneider PD, Callen JP (2002) Frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus. Arch Dermatol 138(9): 1175–8

    Article  PubMed  Google Scholar 

  • Bleumink GS, ter Borg EJ, Ramselaar CG, Ch Stricker BH (2001) Etanercept-induced subacute cutaneous lupus erythematosus Rheumatology 40(11): 1317–9

    Article  PubMed  Google Scholar 

  • Boehm IB, Boehm GA, Bauer R (1998) Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms. Rheumatol Int 18: 59–62

    Article  PubMed  Google Scholar 

  • Bohm M, Gaubitz M, Luger TA, Metze D, Bonsmann G (2003) Topical tacrolimus as a therapeutic adjunct in patients with cutaneous lupus erythematosus — A report of three cases. Dermatology 207:381–385

    Article  PubMed  Google Scholar 

  • Bonsmann, G., Schiller M, Luger TA, and Stander S (2001) Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 44: 925–931.

    Article  PubMed  Google Scholar 

  • Brenner S, Golan H, Gat A, Bialy-Golan A (1997) Paraneoplastic subacute cutaneous lupus erythematosus: report of a case associated with cancer of the lung. Dermatology 194: 172–174

    PubMed  Google Scholar 

  • Brogan BL, Olsen NJ (2003) Drug-induced rheumatic syndromes. Curr Opin Rheumatol. 15(1):76–80.

    Article  PubMed  Google Scholar 

  • Brooke R, Coulson IH, al-Dawoud A (1998) Terbinafine-induced subacute cutaneous lupus erythematosus. Br J Dermatol 139: 1132–1133

    Article  PubMed  Google Scholar 

  • Brown CW, Jr. and Deng JS (1995) Thiazide diuretics induce cutaneous lupus-like adverse reaction. J Toxicol Clin Toxicol 33:729–733.

    PubMed  Google Scholar 

  • Buckley D and Bames L (1995) Childhood subacute cutaneous lupus erythematosus associated with homozygous complement 2 deficiency. Pediatr. Dermatol. 4: 327–30.

    Google Scholar 

  • Cai W, Maldonado M, Werth VP (2000) Differential effects of UVA1 and UVB on skin lesions of MRL/ipr lupus mice. (Abstract) J Invest Dermatol 114: 884

    Google Scholar 

  • Callen JP, Hodge SJ, Kulick KB, Stelzeer G, Buchino JJ (1987) Subacute cutaneous lupus erythematosus in multiple members of a family with C2 deficiency. Arch Dermatol 123: 66–70

    Article  PubMed  Google Scholar 

  • Callen JP, Klein J (1988) Subacute cutaneous lupus erythematosus. Clinical, serologic, immunogenetic, and therapeutic considerations in 72 patients. Arthritis Rheum 31: 1007–1013

    PubMed  Google Scholar 

  • Callen JP, Roth DE, McGrath C, Dromgoole SH (1991a) Safety and efficacy of a broad-spectrum sunscreen in patients with discoid or subacute cutaneous lupus erythematosus. Cutis 47: 130–132, 135–136

    PubMed  Google Scholar 

  • Callen JP, Spencer LV, Burruss JB, Holtman J (1991b) Azathioprine. An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. Arch Dermatol 127: 515–522

    Article  PubMed  Google Scholar 

  • Callen JP (1997) Management of antimalarial-refaractory cutaneous lupus erythematosus. Lupus 6: 203–208

    PubMed  Google Scholar 

  • Callen JP, Hughes AP, and Kulp-Shorten C (2001) Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine — A report of 5 cases. Archives of Dermatology 137:1196–1198.

    PubMed  Google Scholar 

  • Camp PB, Davis LS (1997) Coexistence of subacute cutaneous lupus erythematosus and porphyria cutanea tarda: a case report [letter; comment]. Cutis 59: 216E

    Google Scholar 

  • Caproni M, Cardinali C, Salvatore E, Fabbri P (2001) Subacute cutaneous lupus erythematosus with pityriasis-like cutaneous manifestations Int J Dermatol 40(1): 59–62

    Article  PubMed  Google Scholar 

  • Castenet J, Taillan B, Lacour JP, Garnier G, Perrin C, Ortonne JP (1995) Subacute cutaneous lupus erythematosus associated with Hodgkin’s disease. Clin Rheumatol 14: 692–694

    PubMed  Google Scholar 

  • Chlebus E, Wolska H, Blaszczyk M, Jablonska S (1998) Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus — Diagnostic criteria and therapeutic options. J Am Acad Dermatol 38: 405–412

    PubMed  Google Scholar 

  • Ciconte A, Mills AE, Shipley A, Marks R (2002) Subacute cutaneous lupus erythematosus presenting in a child Australasian J Dermatol 43(1):62–4

    Google Scholar 

  • Cohen LM, Tyring SK, Rády P, Callen JP (1992) Human papillomavirus type II in multiple squamous cell carcinomas in a patient with subacute cutaneous lupus erythematosus. J Am Acad Dermatol 26Suppl: 840–845

    PubMed  Google Scholar 

  • Cohen MR, Crosby D (1994) Systemic disease in subacute cutaneous lupus erythematosus: A controlled comparison with systemic lupus erythematosus. J Rheumatol 21: 1665–1669

    PubMed  Google Scholar 

  • Cohen S, Stastny P, Sontheimer RD (1986) Concurrence of subacute cutaneous lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 29: 421–425

    PubMed  Google Scholar 

  • Cordoba-Guijarro S, Feal C, Dauden E, Fraga J, Garcia-Diez A (2000) Lupus erythematosus-like lesions in a carrier of X-linked chronic granulomatous disease J Euro Acad Dermatol & Venereol 14(5): 409–11

    Google Scholar 

  • Costner MI, Provost TT, and Sontheimer RD (2004) Lupus erythematosus. Chapter 2. In, Cutaneous Manifestations of Rheumatic Diseases. 2nd edition. Lippincott Williams and Wilkins, Philadelphia.

    Google Scholar 

  • Crowson AN, Magro CM (1997) Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy. Human Pathol 28: 67–73

    Article  Google Scholar 

  • Crovato F (1981) Clofazimine in the treatment of annular lupus erythematosus. Arch Dermatol 117: 249–250

    Article  Google Scholar 

  • Dauden E, Bartolome B, Pascual M, Fraga J, Garcia-Diez A (2001) Autoinvolutive photoexa-cerbated tinea corporis mimicking a subacute cutaneous lupus erythematosus Acta Dermato-Venereologica 81(2): 141–2

    Article  PubMed  Google Scholar 

  • David-Bajar KM, Bennion SD, DeSpain JD, Golitz LE, Lee LA (1992) The clinical, histologic and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus. J Invest Dermatol 99: 251–257

    Article  PubMed  Google Scholar 

  • David-Bajar KM, Davis BM (1997) Pathology, immunopathology and immunohistochemistry in cutaneous lupus erythematosus. Lupus 6: 145–157

    PubMed  Google Scholar 

  • Davis BM, Gilliam JN (1984) Prognostic significance of subepidermal immune deposits in un-involved skin of patients with systemic lupus erythematosus: a 10-year longitudinal study. J Invest Dermatol 83: 242–247

    Article  PubMed  Google Scholar 

  • De Silva BD, Plant W, Kemmett D (2001) Subacute cutaneous lupus erythematosus and life-threatening hypokalaemic tetraparesis: a rare complication Br J Dermatol 144(3): 622–4

    PubMed  Google Scholar 

  • DeSpain J, Clark DP (1988) Subacute cutaneous lupus erythematosus presenting as erythroderma. J Am Acad Dermatol 19: 388–392

    PubMed  Google Scholar 

  • Dowdy MJ, Nigra TP, Barth WF (1989) Subacute cutaneous lupus erthematosus during PUVA therapy for psoriasis: Case report and review of the literature. Arthritis Rheum 32: 343–346

    PubMed  Google Scholar 

  • Drosos AA, Dimou GS, Siamopoulou-Mavridou A, Hatzis J, Moutsopoulos HM (1990) Subacute cutaneous lupus erythematosus in Greece. A clinical, serological and genetic study. Ann Med Interne (Paris) 141: 421–424

    Google Scholar 

  • Duong DJ, Spigel GT, Moxley RT, Gaspari AA (1999) American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus. Arch Dermatol 135: 1079–1087

    Article  PubMed  Google Scholar 

  • Fautrel B, Foltz V, Frances C, Bourgeois P, Rozenberg S (2002) Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor alpha-blocking agent: comment on the article by Pisetsky and the letter from Aringer et al. Arthritis & Rheumatism 46(5): 1408–9

    Google Scholar 

  • Feldmann R, Salomon D, Saurat J-H (1994) The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus. Dermatology 189: 425–427

    PubMed  Google Scholar 

  • Fernandez-Diaz ML, Herranz P, Suarez-Marrero MC, Borbujo J, Manzano R, Casado M (1995) Subacute cutaneous lupus erythematosus associated with cilazapril [letter]. Lancet 345: 398

    Article  Google Scholar 

  • Fine RM (1989) Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Int J Dermatol 28: 375–376

    PubMed  Google Scholar 

  • Fishelson Z, Attali G, Mevorach D (2001) Complement and apoptosis. Molecular Immunol 38: 207–219.

    Google Scholar 

  • Flageul B, Wallach D, Cavelier-Balloy B, Bachelez H, Carsuzaa F, Dubertret L (2000) Thalidomide and thrombosis Annales de Dermatologie et de Venereolgie 127(2): 171–4

    Google Scholar 

  • Furner BB (1990a) Treatment of subacute cutaneous lupus erythematosus. Int J Dermatol 29: 542–547

    PubMed  Google Scholar 

  • Furner BB (1990b) Subacute cutaneous lupus erythematosus response to isotretinoin. Int J Dermatol 29: 587–590

    PubMed  Google Scholar 

  • Gange KW, Levene GM (1979) A distinctive eruption in patients receiving oxprenolol. Clin Exp Dermatol 4: 87–97

    PubMed  Google Scholar 

  • Genereau T, Chosidow O, Danel C, Cherin P, Herson S (1999) High-dose intravenous immunoglobulin in cutaneous lupus erythematosus. Arch Dermatol 135: 1124–1125

    Article  PubMed  Google Scholar 

  • Georgala S, Katoulis AC, Hasapi V, Koumantaki-Mathioudaki E (1998) Thalidomide treatment for hypertrophic lupus erythematosus [letter]. Clin Exp Dermatology. 23: 141

    Article  Google Scholar 

  • Gilliam JN, Sontheimer RD (1981) Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 4: 471–475

    PubMed  Google Scholar 

  • Goette DK (1985) Sweet’s syndrome in subacute cutaneous lupus erythematosus. Arch Dermatol 121: 789–791

    Article  PubMed  Google Scholar 

  • Goldberg JW, Lidsky MD (1984) Pulse methylprednisolone therapy for persistent subacute cutaneous lupus. Arthritis Rheum. 27: 837–838

    Google Scholar 

  • Goodfield M, Davison K, Bowden K (2004) Intravenous immunoglobulin (IVIg) for therapy-resistant cutaneous lupus erythematosus (LE). J Dermatolog Treat. 15(1):46–50.

    Article  PubMed  Google Scholar 

  • Gubinelli E, Cocuroccia B, and Girolomoni G (2003) Subacute cutaneous lupus erythematosus induced by nifedipine. J Cutan Med Surg. February 10

    Google Scholar 

  • Gudat W, Bork K (1989) Hereditary angioedema associated with subacute cutaneous lupus erythematosus. Dermatologica 179: 211–213

    PubMed  Google Scholar 

  • Gundmundsen K, Otridge B, Murphy GM (1992) Fulminant fatal lupus erythematosus. Br J Dermatol 126: 303–304

    PubMed  Google Scholar 

  • Gupta G, Roberts DT (1999) Pulsed dye laser treatment of subacute cutaneous lupus erythematosus. Clin Exp Dermatol 24: 498–499

    Article  PubMed  Google Scholar 

  • Haimowitz JE, McCauliffe DP, Seykora J, Werth V (2000) Annular erytherma of Sjogren’s syndrome in a white woman. J Am Acad Dermatol 42: 1069–1073

    Article  PubMed  Google Scholar 

  • Hamilton RG, Harley JB, Bias WB, Roebber M, Reichlin M, Hochberg MC, Arnett FC (1988) Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 31(4):496–505

    PubMed  Google Scholar 

  • Hanjani NM, Nousari CH (2002) Mycophenolate mofetil for the treatment of cutaneous lupus erythematosus with smoldering systemic involvement. Arch Dermatol 138(12): 1616–8

    Article  PubMed  Google Scholar 

  • Harley JP, Reichlin M, Arnett FC, Alexander EL, Bias WB, Provost TT (1986) Gene interaction at the HLA-DQ locus enhances autoantibody production in primary Sjogren’s syndrome. Science 232: 1145–1147

    PubMed  Google Scholar 

  • Herrero C, Bielsa I, Font J, Lozano F, Ericilla G, Lecha M, Ingelman M, Mascaro JM (1988) Subacute cutaneous lupus erythematosus: Clinical pathologic findings in 13 cases. J Am Acad Dermatol 19: 1057–1062

    PubMed  Google Scholar 

  • Ho C, Shumack SP, Morris D (2001) Subacute cutaneous lupus erythematosus associated with hepatocellular carcinoma Australasian J Dermatol 42(2): 110–3

    Article  Google Scholar 

  • Hochedez P, Vasseur E, Staroz F, Morelon S, Roudier Pujol C, Saiag P (2001) Subacute cutaneous lupus gyratus repens Annales de Dermatologie et de Venereologie 128(3 Ptl): 244–6

    PubMed  Google Scholar 

  • Holtman JH, Neustadt DH, Klein J, Callen JP (1990) Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. J Rheumatol 17: 1222–1225

    PubMed  Google Scholar 

  • Ilan Y, Ben Yehuda A (1991) Subacute cutaneous lupus associated with Hashimoto’s thyroiditis. Neth J Med 39: 105–107

    PubMed  Google Scholar 

  • Jewell M, McCauliffe DP (2000) Cutaneous lupus erythematosus patients that smoke are less responsive to antimalarial treatment. J Am Acad Dermatol 42: 983–987

    Article  PubMed  Google Scholar 

  • Johansen PB, Gran JT (1998) Ototoxicity due to hydroxychloroquine — report of two cases. Clin Exper Rheumatol 16: 472–474

    Google Scholar 

  • Johansson-Stephansson E, Koskimes S, Partanen J, Kariniemi AL (1989) Subacute cutaneous lupus erythematosus: Genetic markers and clinical and immunological findings in patients. Arch Dermatol 125: 791–796

    Article  PubMed  Google Scholar 

  • Klein LR, Elmets CA, Callen JP (1995) Photoexacerbation of cutaneous lupus erythematosus due to ultraviolet A emissions from a photocopier. Arthritis Rheum 38: 1152–1156

    PubMed  Google Scholar 

  • Kneitz C, Wilhelm M, Tony HP (2002) Effective B cell depletion with rituximab in the treatment of autoimmune diseases. Immunobiology 206:519–27

    Article  PubMed  Google Scholar 

  • Konstadoulakis MM, Kroubouzos G, Tosca A, Piperingos G, Marafelia P, Konstadoulakis M, et al. (1993) Thyroid autoantibodies in the subsets of lupus erythematosus: Correlation with other autoantibodies and thyroid function. Thyroidol Clin Exp 5: 1–7

    PubMed  Google Scholar 

  • Korb LC, Ahearn JM (1997) Clq binds directly and specifically to surface blebs of apoptotic human keratinocytes — complement deficiency and systemic lupus erythematosus revisited. J Immunol 158: 4525–4528

    PubMed  Google Scholar 

  • Kuhn A, Sonntag M, Richter-Hintz D, Oslislo C, Megahed M, Ruzicka T, Lehmann P (2001) Phototesting in lupus erythematosus: a 15-year experience. J Am Acad Dermatol 45(1): 86–95

    Article  PubMed  Google Scholar 

  • Kuhn A, Sonntag M, Lehmann P, Megahed M, Vestweber D, Ruzicka T (2002a) Characterization of the inflammatory infiltrate and expression of endothelial cell adhesion molecules in lupus erythematosus tumidus. Arch Dermatol Res 294:6–13.

    Article  PubMed  Google Scholar 

  • Kuhn A, Specker C, Ruzicka T, Lehmann P (2002b) Methotrexate treatment for refractory subacute cutaneous lupus erythematosus. J Am Acad Dermatol 46(4): 600–3

    Article  PubMed  Google Scholar 

  • Lanham JG, Hughes GRV (1982) Antimalarial therapy in SLE. Clin Rheumat Disease 8: 279–299

    Google Scholar 

  • Lee LA, Roberts CM, Frank MB, McCubbin VR, Reichlin M (1994) The autoantibody response to Ro/SSA in cutaneous lupus erythematosus. Arch Dermatol 130: 1262–1268

    Article  PubMed  Google Scholar 

  • Lee CW (1998) Prevalences of subacute cutaneous lupus erythematosus and epidermolysis bullosa acquisita among Korean/Oriental populations. Dermatology 197: 187

    PubMed  Google Scholar 

  • Lehmann P, Holzle E, Kind P, Goerz G, Plewig G (1990) Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation [see comments]. J Am Acad Dermatol 22: 181–187

    PubMed  Google Scholar 

  • Leroy DA, Dompmartin A, Le Jean SGJLMJC, Deschamps P (1987) Toxidermie A L’aldactone a type d’erytheme annulaire centrifuge lupique. Ann Dermatol Venereol 114:1237–1240

    PubMed  Google Scholar 

  • Lio D, Candore G, Colombo A, et al. (2001) A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8, DR3 positive subjects: implications for autoimmunity. Hum Immunol 62: 705–713.

    Article  PubMed  Google Scholar 

  • Lipsker D, Dicesare MP, Cribier D, Grosshans E, Heid E (1998) The significance of the ‘dust-like particles’ pattern of immunofluorescence. Br J Dermatol 138: 1039–1042

    Article  PubMed  Google Scholar 

  • Lyon CC, Blewitt R, Harrison PV (1998) Subacute cutaneous lupus erythematosus: Two cases of delayed diagnosis. Acta Derm Venereol 78: 57–59

    Article  PubMed  Google Scholar 

  • M VanHees CL, Boom BW, Vermeer BJ, Daha MR (1992) Subacute cutaneous lupus erythematosus in a patient with inherited deficiency of the third component of complement. Arch Dermatol 128: 700–701

    Article  PubMed  Google Scholar 

  • Maddison PJ (1999) Nature and nurture in systemic lupus erythematosus. Adv Exp Med Biol 455: 7–13

    PubMed  Google Scholar 

  • Marmor MF, Carr RE, Easterbrook M, et al. (2002) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Opthalmology 190: 1377–82.

    Article  Google Scholar 

  • Marmor, MF (2003) New American Academy of Ophthalmology recommendations on screening for hydroxychloroquine retinopathy. Arthritis and Rheumatism 48:1764

    Article  Google Scholar 

  • Marschalko M, Dobozy E, Daroczy J, Gyimesi E, Horvath A (1989) Subacute cutanous lupus erythematosus: A study of 15 cases. Orvosi Hetilap 130: 2623–2628

    PubMed  Google Scholar 

  • Marzano AV, Kolesnikova LV, Gasparni G, Alessi E (1999) Dystrophic calcinosis cutis in subacute lupus. Dermatology 198: 90–92

    Article  PubMed  Google Scholar 

  • Marzano AV, Borghi A, Mercogliano M, Facchetti M, Caputo R (2003a) Nitrendipine-induced subacute cutaneous lupus erythematosus. Eur. J. Dermatol. 13:213–216.

    Article  PubMed  Google Scholar 

  • Marzano AV, Facchetti M, Alessi E (2003b) Poikilodermatous subacute cutaneous lupus erythematosus. Dermatology 207(3):285–90

    Article  PubMed  Google Scholar 

  • Massone C, Parodi A, Rebora A (2000) Erythema multiforme-like subacute cutaneous lupus erythematosus: a new variety? Acta Dermato-Venereologica 80(4):308–9

    Article  PubMed  Google Scholar 

  • McCormack LS, Elgart ML, Turner ML (1984) Annular subacute cutaneous lupus erythematosus responsive to Dapsone. J Am Acad Dermatol 11: 397–401

    PubMed  Google Scholar 

  • McGrath H Jr, Scopelitis E, Nesbitt LT Jr (1990) Subacute cutaneous lupus erythematosus during psoralen ultraviolet A therapy [letter]. Arthritis Rheum 33: 302–303

    PubMed  Google Scholar 

  • McGrath H (1997) Prospects for UV-A1 therapy as a treatment modality in cutaneous lupus erythematosus and systemic LE. Lupus 6: 209–217

    PubMed  Google Scholar 

  • Messenger AG, Church RE (1986) Subacute cutaneous lupus erythematosus and malabsorption. Br J Dermatol 115(supplement 30): 56–57

    Google Scholar 

  • Meymandi S, Wiseman MC, Crawford RI (2003) Tinea faciei mimicking cutaneous lupus erythematosus: a histopathologic case report. J Am Acad Dermatol 48(2 Suppl): S7–8

    Article  PubMed  Google Scholar 

  • Millard TP, McGregor JM (2001) Molecular genetics of cutaneous lupus erythematosus. Clinical and Experimental Dermatol 26: 184–91

    Article  Google Scholar 

  • Millard TP, Kondeatis E, Cox A, Wilson AG, Grabczynska SA, Carey BS, Lewis CM, Khamashta MA, Duff GW, Hughes GR, Hawk JL, Vaughan RW, McGregor JM (2001a) A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo Br J Dermatol 145(2): 229–36

    Article  PubMed  Google Scholar 

  • Millard TP, Kondeatis E, Vaughan RW, Lewis CM, Khamashta MA, Hughes GR, Hawk JL, McGregor JM (2001b) Polymorphic light eruption and the HLA DRB1*0301 extended haplotype are independent risk factors for cutaneous lupus erythematosus. Lupus 10(7): 473–9

    Article  PubMed  Google Scholar 

  • Miyagawa S, Okuchi T, Shiomi Y, Sakamoto K (1989) Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin. J Am Acad Dermatol 21: 343–346

    PubMed  Google Scholar 

  • Modley C, Wood D, Horn T (1989) Metastatic malignant melanoma arising from a common blue nevus in a patient with subacute cutaneous lupus erythematosus. Dermatologica 178: 171–175

    PubMed  Google Scholar 

  • Molad Y, Weinberger A, David M, Garty B, Wysenbeek AJ, Pinkas J (1987) Clinical manifestations and laboratory data of subacute cutaneous lupus erythematosus. Isr J Med. Sci 23: 278–280

    PubMed  Google Scholar 

  • Morgan KW, Callen JP (2001) Calcifying lupus panniculitis in a patient with subacute cutaneous lupus erythematosus: response to diltiazem and chloroquine J Rheumatol 28(9): 2129–32

    PubMed  Google Scholar 

  • Mutasim DF. (2003) Severe subacute cutaneous lupus erythematosus presenting with generalized erythroderma and bullae. J Am Acad Dermatol 48(6):947–9

    Article  PubMed  Google Scholar 

  • Neri R, Mosca M, Bernacchi E, Bombardieri S (1999) A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with Dapsone. Lupus 8: 240–243

    Article  PubMed  Google Scholar 

  • Ng PP, Tan SH, Koh ET, Tan T (2000) Epidemiology of cutaneous lupus erythematosus in a tertiary referral center in Singapore Australasian J Dermatol 41(4): 229–33

    Article  PubMed  Google Scholar 

  • Nieboer C, Tak-Diamand Z, VanLeeuwen-Wallau AG (1988) Dust-like particles: a specific direct immunofluorescence pattern in subacute cutaneous lupus erythematosus. Br J Dermatol 118: 725–734

    PubMed  Google Scholar 

  • Nived O, Johansen PB, Sturfelt G (1993) Standardized ultraviolet-A exposure provokes skin reaction in systemic lupus erythematosus. Lupus 2: 247–250

    PubMed  Google Scholar 

  • Norris DA (1993) Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol 100: 58S–68S

    Article  PubMed  Google Scholar 

  • Nousari HC, Kimyai-Asadi A, Tausk FA (1998) Subacute cutaneous lupus erythematosus associated with beta interferon-la. Lancet 352: 1825–1826

    Article  Google Scholar 

  • Ordi-Ros J, Cortes F, Cucurull E, Maurin M, Bujan S, Vilardell M (2000) Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy. Journal of Phycology 27: 1429–1433

    Google Scholar 

  • Orteu DH, Sontheimer RD, Dutz JP (2001) The pathophysiology of photosensitivity in lupus erythematosus. Photodermatol Photoimmunol Photomed 17:95–113.

    Article  PubMed  Google Scholar 

  • Pantoja L, Gonzalez-Lopez MA, Bouso M, Alija A, Ortiz-Saracho J (2002) Subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis. Scandinavian J Rheumatol 31(6): 377–9

    Article  Google Scholar 

  • Parodi A, Caproni M, Cardinali C, Bernacchi E, Fuligni A, De Panfilis G, Zane C, Papini M, Veller FC, Vaccaro M, Fabbri P, Bader U, Banyai M, Boni R, Burg G, Hafner J (2000) Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus — A review by the Italian Group of Immunodermatology. Dermatology 200: 6–10

    PubMed  Google Scholar 

  • Parodi A, Romagnoli M, Rebora A (1989) Subacute cutaneous lupus erythematosus-like eruption caused by hydrochlorothiazide. Photodermatol 6(2):100–2.

    PubMed  Google Scholar 

  • Parodi A, Rivara G, Guarrera M (1992) Possible naproxen-induced relapse of subacute cutaneous lupus erythematosus. JAMA 268: 51–52

    Article  PubMed  Google Scholar 

  • Patri P, Nigro A, Rebora A (1985) Lupus erythematosus-like eruption from captopril. Acta Derm Venereol 65: 447–448

    PubMed  Google Scholar 

  • Perrotta S, Locatelli F, La Manna A et al. (2002) Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus Br J of Haematol 116:465–7.

    Google Scholar 

  • Piette JC, Sbai A, Frances C (2002) Warning: thalidomide-related thrombotic risk potentially concerns patients with lupus Lupus 11(2): 67–70

    Google Scholar 

  • Pramatarov K, Vassileva S, Miteva L (2000) Subacute cutaneous lupus erythematosus presenting with generalized poiklioderma. J Am Acad Dermatol 42: 286–288

    Article  PubMed  Google Scholar 

  • Price P, Witt C, Allock D, et al. (1999) The genetic basis for the association of the 8.1 ancestral haplotype (Al, B8, DR3) with multiple immunopathological diseases. Immunological Reviews. 167: 257–74.

    PubMed  Google Scholar 

  • Prinz JC, Meurer M, Reiter C, Rieber EP, Plewig G, Riethmuller G (1996) Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412. J Am Acad Dermatol 34: 244–252

    PubMed  Google Scholar 

  • Provost TT, Talal N, Bias W, Harley JB, Reichlin M, Alexander EL (1988) Ro/SS-A positive Sjogren’s/lupus erythematosus overlap patients are associated with the HLA-DR3 and/or DRW6 phenotypes. J Invest Dermatol 91: 369–371

    PubMed  Google Scholar 

  • Racila DM, Sontheimer CJ, Sheffield A, Wismeski JJ, Racila E, Sontheimer RD, (2003) Homozygous single nucleotide polmorphism of the complement C1QA gene is associated with decreased levels of Clq in patients with subacute cutaneous lupus erythematosus. Lupus 12(2): 124–32

    Article  PubMed  Google Scholar 

  • Rahman P, Gladman DD, Urowitz MB (1998) Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. J Rheumatol 25: 1716–1719

    PubMed  Google Scholar 

  • Rao BK, Coldiron BM, Freeman RF, Sontheimer RD (1990) Subacute cutaneous lupus erythematosus lesions progressing to morphea. J Am Acad Dermatol 23: 1019–1022

    PubMed  Google Scholar 

  • Reed BJ, Huff JC, Jones SK, Orton DW, Lee LA, Norris DA (1985) Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med 103: 49–51

    PubMed  Google Scholar 

  • Reichlin M (2000)ANA negative systemic lupus erythematosus sera revisited serologically Lupus 9(2): 116–9

    Article  PubMed  Google Scholar 

  • Richardson TT, Cohen PR (2000) Subacute cutaneous lupus erythematosus: report of a patient who subsequently developed a meningioma and whose skin lesions were treated with isotretinoin. Cutis 66: 183–188

    PubMed  Google Scholar 

  • Rihner M, McGrath H, Jr. (1992) Fluorescent light photosensitivity in patients with systemic lupus erythematosus. Arthritis Rheum 35: 949–952

    PubMed  Google Scholar 

  • Ross S, Dywer C, Ormerod AD, Herriot R, Roberts C (2002) Subacute cutaneous lupus erythematosus associated with phenytoin. Clinical & Experimental Dermatology 27:474–476

    Google Scholar 

  • Roura M, Lopez-Gil F, Umbert P (1991) Systemic lupus erythematosus exacerbated by piroxicam. Dermatologica 182:56–58.

    PubMed  Google Scholar 

  • Roustan G, Salas C, Barbadillo C, Sanchez Yus E, Mulero J, Simon A (2000) Lupus erythematosus with an erythema multiforme-like eruption Eur J Dermatol 10: 459–462

    PubMed  Google Scholar 

  • Rowell NR, Swanson-Beck J, Andrson JR (1963) Lupus erythematosus and erythema multi-forme-like lesions. Arch Dermatol 88: 176–180

    PubMed  Google Scholar 

  • Rua-Figueroa I, Erausquin C, Naranjo A, Carretero-Hemandez G, Rodriguez-Lozano C, De la RP (1999) Pustuloderma during cutaneous lupus treatment with thalidomide [letter]. Lupus 8: 248–249

    Article  PubMed  Google Scholar 

  • Rubin, RL (2002) Drug-Induced Lupus. In Dubois’ Lupus Erythematosus. D.J. Wallace and B.H. Hahn, editors. Lippincott Williams and Wilkins, Philadelphia.

    Google Scholar 

  • Rudnicka L, Szymanska E, Walecka I, Slowinska M (2000) Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus: a report of three cases. Dermatology 200: 129–131

    Article  PubMed  Google Scholar 

  • Sanders CJ, Van Weelden H, Kazzaz GA, Sigurdsson V, Toonstra J, Bruijnzeel-Koomen CA. (2003) Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol. Br J Dermatol 149(1):131–7

    Article  PubMed  Google Scholar 

  • Schanz S, Ulmer A, Rassner G, Fierlbeck G (2002) Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil Br J Dermatol 147(1): 174–8

    Article  PubMed  Google Scholar 

  • Scheinman PL (1994) Acral subacute cutaneous lupus erythematosus: an unusual variant. J Am Acad Dermatol 30: 800–801

    PubMed  Google Scholar 

  • Schulz EJ, Menter MA (1971) Treatment of discoid and subacute cutaneous lupus erythematosus with cyclophosphamide. Br J Dermatol 85: 60–65

    Google Scholar 

  • Sheretz EF (1988) Lichen planus following procainamide inducedlupus erythematosus. Cutis 42: 51–53

    PubMed  Google Scholar 

  • Siamopoulou-Mavridou A, Stefanou D, Dross AA (1989) Subacute lupus erythematosus childhood. Clin. Rheum. 8: 533–7.

    Article  Google Scholar 

  • Sonnichsen N, Meffert H, Kunzelmann V, Audring H (1993) [UV-A-1 therapy of subacute cutaneous lupus erythematos us]. [German]. Hautarzt 44: 723–725

    PubMed  Google Scholar 

  • Sonntag M, Lehmann P, Megahed M, Ruzicka T, Kuhn A. (2003) Papulonodular mucinosis associated with subacute cutaneous lupus erythematosus. Dermatology 206(4): 326–9

    Article  PubMed  Google Scholar 

  • Sontheimer RD, Gilliam JN (1979) A reappraisal of the relationship between subepidermal immunoglobulin deposits and DNA antibodies in systemic lupus erythematosus: a study using the Crithidia luciliae immunofluorescence anti-DNA assay. J Invest Dermatol 72: 29–32

    Article  PubMed  Google Scholar 

  • Sontheimer RD, Thomas JR, Gilliam JN (1979) Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinctlupus erythematosus subset. Arch Dermatol 115: 1409–1415

    Article  PubMed  Google Scholar 

  • Sontheimer RD, Stastny P, Gilliam JN (1981) Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus. J Clin Invest 67: 312–316

    PubMed  Google Scholar 

  • Sontheimer RD, Maddison PJ, Reichlin M, Jordan RE, Stastny P, Gilliam JN (1982) Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med 97: 644–671

    Google Scholar 

  • Sontheimer RD (1985) Clinical significance of subacute cutaneous lupus erythematosus skin lesions. J Dermatol 12: 205–212

    PubMed  Google Scholar 

  • Sontheimer RD (1989) Subacute cutaneous lupus erythematosus: a decade’s perspective. Med Clin North Am 73: 1073

    PubMed  Google Scholar 

  • Sontheimer RD, Provost TT (1996) Lupus erythematosus. In Sontheimer RD, Provost TT (eds) Cutaneous Manifestations of Rheumatic Diseases. Williams and Wilkins, Baltimore, p 31

    Google Scholar 

  • Srivastava, M, Rencic A, Diglio G, Santana H, Bonitz P, Watson R, Ha E, Anhalt GJ, Provost TT, Nousari CH (2003) Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol 139:45–49.

    Article  PubMed  Google Scholar 

  • Stege H, Budde MA, Grether-Beck S, Krutmann J (2000) Evaluation of the capacity of sunscreens to photoprotect lupus erythematosus patients by employing the photoprovocation test Photodermatol, Photoimmunol, & Photomed 16(6): 256–9

    Google Scholar 

  • Stevens RJ, Andujar C, Edwards CJ, Ames PR, Barwick AR, Khamashta MA, Hughes GR (1997) Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients. Br J Rheumatol 36: 353–359

    Article  PubMed  Google Scholar 

  • Tebbe B, Orfanos CE (1997) Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 6: 96–104

    PubMed  Google Scholar 

  • Tebbe B, Mansmann U, Wollina U, Auergrumbach P, Lichtmbalyohere A, Arensmeier M, Orfanos CE (1997) Markers in cutaneous lupus erythematosus indicating systemic involvement — A multicenter study on 296 patients. Acta Dermato-Venereol 77: 305–308

    Google Scholar 

  • Thivolet J, Nicolas JF, Kanitakis J, Lyonnet S, Chouvet B (1990) Recombinant interferon a2a is effective in the treatment of discoid and subacute cutaneous lupus erythematosus. Br J Dermatol 122: 405–409

    PubMed  Google Scholar 

  • Ting W, Sontheimer RD (2001) Local therapy for cutaneous LE and systemic LE: Practical and theoretical consideration. Lupus 10: 171–189

    Article  PubMed  Google Scholar 

  • Toll A, Campo-Pisa P, Gonzalez-Castro J, Campo-Voegeli A, Azon A, Iranzo P, Lecha M, Herrero C (1998) Subacute cutaneous lupus erythematosus associated with cinnarizine and thiethylperazine therapy. Lupus 7: 364–366

    Article  PubMed  Google Scholar 

  • Topaloglu R, Bakkaloglu A, Slingsby JH et al. (2000) Survey of Turkish systemic lupus erythematosus patients for a particular mutation of C1Q deficiency. Clinical and Experimental Rheumatol 18:75–77

    Google Scholar 

  • Trenholme GM, Carson PE (1978) Therapy and prophylaxis of malaria. JAMA 240: 2293–229

    Article  PubMed  Google Scholar 

  • Valeski JE, Kumar V, Forman AB, Beutner EH, Chorzelski TP (1992) J Am Acad Derm 27: 194–198

    PubMed  Google Scholar 

  • Vasquez-Doval J, Ruiz de Erenchun F, Sanchz-Ibarrola A, Contrera F, Soto de Delas J, Quintanilla E (1992) Subacute cutaneous lupus erythematosus — clinical, histopathological and immunophenotypical study of five cases. J Invest Allerg 2: 27–32

    Google Scholar 

  • Velthuis PJ, Kater L, Van der Tweel I, Baart de la Faille H, Van Vloten WA (1992) Immunofluorescence microscopy of healthy skin from patients with systemic lupus erythematosus: More than just the lupus band. Ann Rheum Dis 51: 720–725

    PubMed  Google Scholar 

  • Walport MJ, Davies KA, Botto M (1998) Clq and systemic lupus erythematosus. Immunobiol 199: 265–85

    PubMed  Google Scholar 

  • Warren KJ, Nopper AJ, Crosby DL (1998) Thalidomide for recalcitrant discoid lesions in a patient with systemic lupus erythematosus. J Am Acad Dermatol 39: 293–295

    PubMed  Google Scholar 

  • Watson RM, Talwar P, Alexander E, Bias WB, Provost TT (1991) Subacute cutaneous lupus erythematosus-immunogenetic associations. J Autoimmun 4: 73–85

    Article  PubMed  Google Scholar 

  • Wenzel J, Bauer R, Bieber T, Bohm I (2000) Autoantibodies in patients with lupus erythematosus: spectrum and frequencies Dermatology 201(3): 282–3

    Article  PubMed  Google Scholar 

  • Wenzel J, Bauer R, Uerlich M, Bieber T, Boehm I (2002) The value of lymphocytopenia as a marker of systemic involvement in cutaneous lupus erythematosus Br J Dermatol 146(5): 869–71

    Article  PubMed  Google Scholar 

  • Werth VP, Zhang W, Dortzbach K, Sullivan, K (2000) Association of a promoter polymorphism of tumor necrosis factor-alpha with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription. J Invest Dermatol 115: 726–730

    Article  PubMed  Google Scholar 

  • Wollina U, Barta U, Uhlemann C, Oelzner P (1999) Lupus erythematosus-associated red lunula. J Am Acad Dermatol 41: 419–421

    PubMed  Google Scholar 

  • Wollina U, Schreiber G (2003) Polyglandular autoimmune syndrome type II (Schmidt’s syndrome) in patients with autoimmune connective tissue disorders. J Eur Acad Derm Venereol 17(3): 371–2

    Article  Google Scholar 

  • Yung RL, Richardson BC (1995) Cytarabine therapy for refractory cutaneous lupus. Arthritis Rheum 38:1341–1343

    PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Wien

About this chapter

Cite this chapter

Pellowski, D.M., Kihslinger, J.E., Sontheimer, R.D. (2005). Subacute Cutaneous and Systemic Lupus Erythematosus. In: Hertl, M. (eds) Autoimmune Diseases of the Skin. Springer, Vienna. https://doi.org/10.1007/3-211-27377-8_10

Download citation

  • DOI: https://doi.org/10.1007/3-211-27377-8_10

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-20686-7

  • Online ISBN: 978-3-211-27377-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics